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Abstract
To determine the presence and functional role of the histamine H2 receptor (H2R) palmitoylation, a receptor with a Cys305
to Ala (A305 receptor) mutation was generated. Wild-type (WT) and A305 receptors were tagged at their N-termini with a
hemagglutinin (HA) epitope. WT, but not A305, receptors incorporated [3H]palmitate by metabolic labeling, indicating that
the H2R is palmitoylated at Cys305. Immunocytochemistry of WT and A305 receptors expressed in COS7 cells revealed WT
receptors to be distributed at the plasma membrane, while the majority of A305 receptors were localized intracellularly with
only a small portion being at the plasma membrane. However, the affinity of the A305 receptor for tiotidine was comparable
to that of the WT receptor. In addition, when the amounts of cell surface receptors as determined by anti-HA antibody
binding were equivalent, A305 receptors mediated production of more cAMP than WT receptors. Preincubation of COS7 cells
expressing each receptor with 1035 M histamine for 30 min reduced subsequent cAMP production in response to histamine
via the receptors to similar extents, indicating that palmitoylation is not necessary for desensitization. In addition, cell surface
A305 receptors were capable of being internalized from the cell surface at a rate and extent similar to those of WT receptors.
Finally, CHO cell lines stably expressing either WT or A305 receptors were incubated with 1035 M histamine for 1, 6, 12 and
24 h. Total amounts of WT and A305 receptors, as determined by tiotidine binding, were reduced by incubation, indicating
downregulation. Downregulation of the A305 receptor was more extensive than that of the WT receptor. Thus,
palmitoylation of the H2R might be important for targeting to the cell surface and stability. ß 2001 Elsevier Science B.V.
All rights reserved.
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1. Introduction
Several G protein-coupled receptors (GPCRs) are
reportedly modi¢ed by palmitate at highly conserved
Cys residues located in the C-terminus [1^10]. Palmi-
toylation of GPCRs has been reported to be involved
in agonist-induced internalization [5], and agonist-in-
duced downregulation [11]. In addition, GPCR pal-
mitoylation has been implicated in the regulation of
adenylyl cyclase stimulation via the L2-adrenoceptor
by rendering its C-terminus relatively inaccessible to
receptor kinases [12,13]. Thus, the roles of GPCR
palmitoylation vary among receptors. Cys residues
at corresponding positions are conserved in other
GPCRs including the histamine H2 receptor (H2R)
[14^16]. To date, no data have been presented con-
cerning palmitoylation of H2R. The purpose of this
study was, therefore, to examine whether the canine
H2R, which contains a Cys residue at position 305 in
the C-terminal region, is palmitoylated and, if so, to
assess its functional roles. Herein, using a mutant
H2R in which Cys305 had been replaced with Ala,
we were able to demonstrate that the H2R is palmi-
toylated at Cys305. Using this mutated receptor, we
attempted to elucidate the role of palmitoylation in
cAMP production via adenylyl cyclase as well as the
intracellular distribution of the receptor.
2. Experimental procedures
2.1. Materials
[3H]Palmitate was obtained from Moravek. 12CA5
monoclonal antibody against the hemagglutinin
(HA) nine-amino epitope was purchased from Boehr-
inger Mannheim (Germany), 125I-goat anti-mouse
IgG from ICN, and pBacPAK9 from Clontech
(Palo Alto, CA, USA).
2.2. Construction of palmitoylation-defective
H2R cDNA
Full-length canine H2R cDNA was subcloned into
the EcoRI site of pUC19. A mutant H2R cDNA
(C305CA, A305) was prepared by site-directed muta-
genesis. Mutagenesis was performed by polymerase
chain reaction using 25-mer (GCTCTTCCGCGCG-
AGGCCGGCCAGC) and 25-mer (TGGCCGGCC-
TGGCGCGGAAGAGCTG). Then, a nine-amino
acid HA epitope (YPYDVPDYA) was inserted into
the N-termini of the WT and mutant receptors. The
cDNAs encoding the WT H2R and its mutants with
or without the HA epitope were subcloned into
pCAGGS. COS7 cells were transfected with varying
amounts of plasmid DNAs by the DEAE^dextran
method. Transfection into Chinese hamster ovary
(CHO) cells was performed employing the calcium
phosphate precipitation method. Several clones resis-
tant to 600 Wg/ml G418 were isolated [17].
2.3. Production of recombinant H2R baculovirus
For expression in Sf9 cells, N-glycosylation-defec-
tive H2Rs, HA-Q4;162;168 and its mutant HA-
Q4;162;168A305, were used. N-Glycosylation-defective
H2Rs migrated as a sharp band on immunoblotting
of membrane fractions from COS7 cells or CHO cells
and were easier to identify [18]. The cDNAs were
subcloned into pBacPAK9, a baculovirus vector.
The recombinant baculoviruses were produced ac-
cording to the manufacturer’s instructions. Sf9 cells
were grown as monolayers or in suspension culture
in TC100 medium containing 10% fetal calf serum
and 50 Wg/ml kanamycin at 27‡C. Sf9 cells were in-
fected with the appropriate virus at a multiplicity of
infection of 2^5 and harvested at 48 h post infection.
2.4. Immunoprecipitation and immunoblotting of
H2Rs
At 48 h post infection, Sf9 cells expressing HA-
Q4;162;168 or HA-Q4;162;168A305 receptors were lysed
in 1% Triton X/phosphate-bu¡ered saline (PBS)
with 1 mM phenylmethylsulfonyl £uoride, 10 Wg/ml
leupeptin, 0.1 mg/ml bacitracin, 0.1 Wg/ml pepstatin
A, 10 Wg/ml soybean trypsin inhibitor and 100 units/
ml aprotinin. The samples were centrifuged at
10 000Ug at 4‡C for 10 min, and the supernatants
were then incubated with 2 Wg of anti-HA monoclo-
nal antibody, 12CA5, conjugated to protein G Se-
pharose at 4‡C for 2 h. The immunocomplexes re-
covered by centrifugation were washed ¢ve times
with PBS containing 1% Triton X-100, then boiled
in Laemmli sample bu¡er. The samples were sub-
jected to sodium dodecyl sulfate^polyacrylamide gel
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electrophoresis (SDS^PAGE) and then transferred to
nitrocellulose ¢lters. The ¢lters were incubated with
antibody against the 14 C-terminal amino acids of
the H2R (aH2RCT antibody) [17]. The proteins
were visualized by enhanced chemiluminescence
(ECL) using horseradish peroxidase-labeled anti-rab-
bit IgG.
2.5. Labeling of infected Sf9 cells with [3H]palmitate
Sf9 cells infected with the baculoviruses containing
cDNAs encoding HA-Q4;162;168 and HA-Q4;162;168A305
receptors were cultured for 18 h prior to the labeling
experiment in serum free medium containing 0.1%
fatty acid free bovine serum albumin (BSA). The
serum free medium was replaced with serum free
medium containing 0.5 mCi/ml [3H]palmitate and
0.1% fatty acid free BSA and incubated at 27‡C for
4 h. Then, the cells were washed twice with ice-cold
PBS and lysed in PBS containing 1% Triton X. Next,
the samples were subjected to immunoprecipitation
with anti-HA monoclonal antibody, 12CA5, and
SDS^PAGE. Then, the gels were placed in ¢xative
(40% methanol/10% acetic acid/3% glycerol) for 4 h
and then immersed in either 1 M Tris^HCl, pH 7.0
or 1 M hydroxylamine, pH 7.0 for 12 h at room
temperature. After washing with 2-propanol/water
(1:1, v/v), the gels were exposed to Kodak X-Omat
¢lms at 380‡C for 30 days.
2.6. Quanti¢cation of cell surface H2Rs
At 24 h post transfection, COS7 cells expressing
HA-WT and HA-A305 receptors or parental COS7
cells were plated onto 24-well plates at a density of
105 cells/well. At 48 h post transfection, cells were
incubated in HEPES^tyrode’s bu¡er (140 mM
NaCl, 2.7 mM KCl, 1.8 mM CaCl2, 0.49 mM
MgCl2, 0.37 mM NaH2PO4, 5.6 mM glucose, 25
mM HEPES, pH 7.4) containing 0.1% BSA at
37‡C for 30 min. After incubation in the presence
or absence of 1035 M histamine at 37‡C for the in-
dicated times, the cells were ¢xed with PBS contain-
ing 3% paraformaldehyde, washed again with PBS
and incubated with 5% skim milk/PBS for 1 h at
room temperature. They were incubated with 200
Wl of 12CA5 (5 Wg/ml) in PBS for 2 h at room tem-
perature, washed again with PBS, and incubated for
one additional hour with 200 Wl of 125I-goat anti-
mouse IgG (1/200 dilution) at room temperature.
The wells were then washed twice with 5% skim
milk/PBS, twice with PBS, and three times with
0.05% Tween 20/PBS. Bound 125I-goat anti-mouse
IgG was solubilized in 1% SDS, and radioactivities
were determined in a Q-counter. Speci¢c binding was
determined by subtraction of the non-speci¢c binding
observed in parental COS7 cells.
2.7. Tiotidine binding assay
Tiotidine binding in membranes was assessed as
described previously, with some modi¢cations [17].
Membrane fractions (200 Wg) from COS7 cells were
incubated with 1 nM [3H]tiotidine and varying con-
centrations of unlabeled tiotidine in 25 mM HEPES,
0.1% BSA, pH 7.4, in a ¢nal volume of 200 Wl at
37‡C for 2 h. The binding reaction was terminated by
¢ltration over GF/C glass ¢ber ¢lters, followed by 10
ml washes with ice-cold incubation bu¡er. Radioac-
tivity on the ¢lters was determined by liquid scintil-
lation counting. Speci¢c binding was calculated by
subtraction of the non-speci¢c binding determined
in the presence of 1034 M ranitidine. No speci¢c
binding was observed in either parental COS7 cells
or COS7 cells transfected with the expression vector
alone. Similar experiments were performed in CHO
cells stably expressing WT or A305 receptors.
2.8. Measurement of cAMP productions
COS7 cells, plated onto 24-well plates, were as-
sayed at a density of 1U105 cells/well, as described
previously [18,19]. The cells were incubated for 30
min at 37‡C in 450 Wl of HEPES^tyrode’s bu¡er
containing 0.1% BSA and 0.1 mM 3-isobutyl-1-meth-
ylxanthine, then 50 Wl of histamine solution were
added to initiate the reaction. After 10 min of incu-
bation at 37‡C, the reaction was terminated by add-
ing 500 Wl of 12% trichloroacetic acid. The samples
were centrifuged for 5 min at 3000Ug at 4‡C. Fol-
lowing extraction of the supernatants three times
with diethyl ether, cAMP contents in the samples
were measured using a radioimmunoassay. Hista-
mine-dependent and forskolin-dependent cAMP pro-
ductions were determined by subtracting basal
cAMP productions.
BBAMCR 14759 13-6-01
Y. Fukushima et al. / Biochimica et Biophysica Acta 1539 (2001) 181^191 183
2.9. Immunocytochemical localization of H2R in
COS7 cells
For immuno£uorescence microscopy, COS7 cells
were ¢xed in 3% paraformaldehyde/PBS, scraped
o¡ the dish with a rubber blade, and embedded in
10% gelatin/PBS. Semithin frozen sections (1 Wm
thick) were cut and incubated with anti-H2RCT anti-
body. These sections were then incubated with rhod-
amine-labeled a⁄nity puri¢ed goat anti-mouse or
anti-rabbit IgG (Jackson Immunoresearch, West
Grove, PA, USA) [20].
3. Results
3.1. Palmitoylation of the H2R
To determine the occurrence of H2R palmitoyla-
tion, we made use of the baculovirus/Sf9 expression
system, which allows e⁄cient expression of receptors.
In addition, we utilized N-glycosylation-defective
H2Rs, which retain the functions of the normal
WT receptor and migrate as a sharp band on SDS^
PAGE [18]. The receptor tagged with the HA epitope
at its N-terminus (termed HA-Q4;162;168 receptor) and
recombinant baculoviruses were produced. At 48 h
post transfection the infected Sf9 cells were lysed and
immunoprecipitated with 12CA5, a monoclonal anti-
body against the HA epitope. Successful expression
of the HA-tagged receptors is shown in Fig. 1A (lane
2). There are at least four immunoreactive bands
with molecular masses of 31.5 þ 2.5 kDa, 59.0 þ 6.0
kDa, 80.5 þ 4.5 kDa and 120 kDa, respectively. The
di¡erences in molecular mass are not due to di¡erent
extents of N-glycosylation, because the receptors we
used were devoid of all potential N-glycosylation
sites (Asn4, Asn162 and Asn168). Rather, these bands
apparently correspond to oligomers of H2Rs as we
have previously reported [21]. Sf9 cells, infected with
HA-Q4;162;168 receptor virus, were isotopically labeled
with [3H]palmitate, lysed in PBS containing 1% Tri-
ton X, and the receptors were immunoprecipitated
with anti-HA monoclonal antibody. As shown Fig.
1B lane 3, 3H-labeled bands with molecular masses
corresponding to the immunoprecipitated HA-
Fig. 1. (A) Expression of H2Rs in Sf9 cells. Parental Sf9 cells and Sf9 cells infected with the HA-Q4;162;168 and HA-Q4;162;168A305 re-
ceptor recombinant baculoviruses, respectively, were harvested, solubilized in 1% Triton X bu¡er, and immunoprecipitated with 2 Wg
of anti-HA monoclonal antibody conjugated to protein G Sepharose as described in Section 2. Samples were subjected to SDS^PAGE
and transferred to nitrocellulose ¢lters. H2R proteins were detected using anti-H2RCT antibody and the ECL system. Lanes: 1 and 3,
parental Sf9 cells ; 2, HA-Q4;162;168 receptor; 4, HA-Q4;162;168A305 receptor. (B) Cys305 to Ala mutation eliminates detectable
[3H]palmitate incorporation into the canine H2R. Parental Sf9 cells and Sf9 cells infected with HA-Q4;162;168 receptor and HA-
Q4;162;168A305 receptor recombinant baculoviruses, respectively, were metabolically labeled in the presence of 0.5 mCi/ml [3H]palmitate
for 4 h at 27‡C. Immunoprecipitation was performed as described in Section 2. The samples were subjected to SDS^PAGE and the
gels were dried and exposed to a Kodak X-Omat ¢lm at 380‡C for 30 days. Lanes: 1, parental Sf9 cells ; 2, HA-Q4;162;168A305 recep-
tor; 3, HA-Q4;162;168 receptor; 4, HA-Q4;162;168 receptor with hydroxylamine treatment. Immunoblotting was also performed with the
immunoprecipitated samples using anti-H2RCT antibody and the ECL system. Lanes: 5, parental Sf9 cells ; 6, HA-Q4;162;168A305 recep-
tor; 7, HA-Q4;162;168 receptor. The results are typical of three experiments.
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Q4;162;168 receptor were observed. In addition, neutral
hydroxylamine treatment removed the [3H]palmitate
incorporated into HA-Q4;162;168 receptors, suggesting
that palmitoylation occurs on a Cys residue. This
shows that H2R is a palmitoylation substrate (Fig.
1B, lane 4). To determine whether palmitoylation
takes place at the conserved Cys305, we constructed
a cDNA for a mutant H2R, the Cys305 of which had
been replaced by Ala (HA-A305). As shown in Fig.
1A (lane 4), HA-Q4;162;168A305 receptors were ex-
pressed in Sf9 cells. However, no 3H labeling was
observed following [3H]palmitate labeling of the Sf9
cells infected with the HA-Q4;162;168A305 virus (Fig.
1B, lane 2). The di¡erence in 3H labeling between
the HA-Q4;162;168 and the HA-Q4;162;168A305 receptors
cannot be explained by diminished uptake or incor-
poration of [3H]palmitate by HA-Q4;162;168A305 cells,
since SDS^PAGE of total cell homogenates from
both cell types revealed identical incorporation of
3H label into total cellular proteins (data not shown).
These ¢ndings suggest that the H2R is palmitoylated
at Cys305. Neither can decreased HA-Q4;162;168A305
receptor expression account for the di¡erence in 3H
labeling (Fig. 1B, lane 6).
3.2. Subcellular localization of WT and A305 receptors
To investigate the functional signi¢cance of palmi-
toylation of the H2R, WT and A305 receptors were
transiently expressed in COS7 cells. Fusion genes en-
coding the WT and A305 receptors tagged at their N-
termini, with the HA epitope, were prepared and
subcloned into the mammalian expression vector
pCAGGS. These receptors as well as those without
the HA epitope were expressed in COS7 cells.
Immunocytochemistry of COS7 cells showed both
WT and HA-WT receptors to be distributed mainly
at the plasma membrane (Fig. 2A). In contrast, the
majority of A305 and HA-A305 receptors were distrib-
uted intracellularly with only small portions at the
plasma membrane (Fig. 2A). The di¡erence in sub-
cellular distribution between WT and A305 receptors
was not due to a di¡erence in expression level, be-
cause comparable amounts of each receptor type
were expressed in COS7 cells based on tiotidine bind-
ing (Fig. 2B). Furthermore, HA tagging at the N-
terminus did not a¡ect the normal distribution of
the receptors. Thus, the di¡erence in subcellular dis-
Fig. 2. (A) Immunocytochemical localization of WT and A305 receptors in COS7 cells. COS7 cells on 10 cm dishes were transfected
with 3 Wg of each plasmid DNA (a, WT; b, A305 ; c, HA-WT; d, HA-A305 receptor). At 48 h post transfection, COS7 cells were ¢xed
in 3% paraformaldehyde/PBS. Thin sections were prepared and immunostained with anti-HA antibody (c,d) or anti-H2RCT antibody
(a,b). Scale bar, 10 Wm. (B) Scatchard plot analysis of the tiotidine binding data for WT and A305 receptors. COS7 cells on 10 cm
dishes were transfected with 3 Wg of each plasmid DNA (WT, A305, HA-WT and HA-A305 receptors). At 48 h post transfection,
COS7 cells were harvested and membrane fractions prepared. Membranes (200 Wg) thus prepared were incubated with 1 nM
[3H]tiotidine and increasing concentrations of unlabeled tiotidine at 37‡C. Non-speci¢c binding was determined in the presence of
1034 M ranitidine. Data shown are representative of three experiments performed in duplicate. a, WT receptor; E, A305 receptor; b,
HA-WT receptor; F, HA-A305 receptor.
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Fig. 4. E¡ect of histamine treatment on subsequent cAMP accumulation. COS7 cells were transfected with plasmid DNAs containing
HA-WT (0.3 Wg/10 cm plate) or HA-A305 (1.5 Wg/10 cm plate) receptors. Transfection with these DNA amounts resulted in similar
levels of cell surface expression of HA-WT and HA-A305 receptors. At 48 h post transfection, COS7 cells expressing HA-WT or HA-
A305 receptors were preincubated in the presence or absence of 1035 M histamine for 30 min at 37‡C. Subsequently, the cells were
washed and either varying concentrations of histamine (A) or 1034 M forskolin (B) were added to the cells, which had been preincu-
bated with histamine. Incubations were continued for an additional 10 min at 37‡C and reactions were then terminated by adding tri-
chloroacetic acid. b,F, preincubation with vehicle; a,E, preincubation with histamine. Shown are the means þ S.E. of three individual
experiments, each performed in triplicate. When not shown, S.E. values were so small that they fell within the symbols.
Fig. 3. Relationship between the numbers of cell surface receptors expressed and cAMP productions via WT and A305 receptors. At
48 h post transfection, COS7 cells expressing HA-WT or HA-A305 receptors on 24-well plates at a density of 105 cells/well were prein-
cubated in HEPES^tyrode’s bu¡er containing 0.1% BSA and 0.1 mM 3-isobutyl-1-methylxanthine for 30 min, then incubated for an
additional 10 min in the absence or presence of 1037 M (A) or 1035 M (B) histamine. Incubation was terminated by adding trichloro-
acetic acid. cAMP contents were measured by radioimmunoassay. b, HA-WT; F, HA-A305. Data (mean þ S.E.) are from one of three
representative experiments performed in triplicate. When not shown, S.E. values were so small that they fell within the symbols.
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tribution of the palmitoylation-defective receptors
was attributable to lack of palmitoylation.
3.3. Adenylyl cyclase coupling of the WT and A305
receptors
We next attempted to de¢ne the role of palmitoy-
lation in H2R coupling to adenylyl cyclase. Plasma
membrane localizations of WT and A305 receptors
di¡ered markedly, making it di⁄cult to compare
the abilities of the receptors to produce cAMP in
response to histamine even when the total amounts
of expressed receptors were similar. cAMP produc-
tions mediated by these receptors can be compared
only when the amounts of cell surface receptors per
cell are equivalent. Furthermore, measurement of the
amounts of cell surface H2Rs is extremely di⁄cult.
The acid wash method [22] was not applicable to
H2R due to high levels of non-speci¢c uptake of
histamine and [3H]histamine. In addition, there are
no appropriate hydrophilic radioligands speci¢c for
the H2R [23]. Thus, to quantitatively determine the
amounts of cell surface WT and A305 receptors, the
amounts of cell surface anti-HA antibody binding
were measured. Various amounts of plasmid DNAs
for HA-WT and HA-A305 receptors were transfected
into COS7 cells. Importantly, the amount of plasmid
DNA a¡ected the number of H2Rs expressed per cell
and the percentage of transfected cells was constant
even when the amounts of plasmid DNA used were
not equivalent, as reported previously [24]. cAMP
productions in response to histamine at each expres-
sion level in COS7 cells expressing HA-WT and HA-
A305 receptors are shown in Fig. 3. Interestingly, the
HA-A305 receptor was more potent in terms of stim-
ulating adenylyl cyclase than the HA-WT receptor
when cell surface receptor expression per cell was
equivalent. Basal levels of cAMP production were
similar between HA-WT and HA-A305 receptors
(not shown). Thus, palmitoylation of the H2R is
not essential for functional coupling of this receptor
to adenylyl cyclase stimulation. Although the per-
centage of cell surface receptors was not determined,
functional coupling of the palmitoylation-defective
receptor to adenylyl cyclase was also observed in
CHO cell lines stably expressing A305 receptors (not
shown).
3.4. Role of palmitoylation in homologous
desensitization, agonist-induced internalization,
and agonist-induced downregulation
We examined the e¡ect of preincubation of HA-
WT and HA-A305 cells with 1035 M histamine on
subsequent cAMP production. COS7 cells were
transfected with plasmid DNAs containing HA-WT
(0.3 Wg/10 cm plate) or HA-A305 (1.5 Wg/10 cm plate)
receptors. Transfection with these DNA amounts re-
sulted in similar levels of cell surface expression of
HA-WT and HA-A305 receptors. Preincubation of
transfected COS7 cells with 1035 M histamine for
30 min led to reduced cAMP productions in both
HA-WT and HA-A305 cells as compared with un-
treated cells (Fig. 4A), indicating desensitization,
while forskolin-dependent cAMP production was
not altered (Fig. 4B). Since the transfection e⁄ciency
of the COS7 cell system is approx. 20% at best, the
results shown in Fig. 4B do not necessarily mean that
forskolin-dependent cAMP production in COS7 cells
expressing the receptors was not altered. Therefore,
we performed similar experiments in CHO cells sta-
bly expressing HA-WT or HA-A305 receptors and
found that histamine-dependent cAMP production
via these receptors was reduced by preincubation
with 1035 M histamine, while forskolin-dependent
cAMP production was una¡ected (not shown). These
results suggest that palmitoylation of the H2R is not
essential for desensitization of the receptor-mediated
cAMP response. Similar results were obtained em-
ploying a 15 min incubation with 1035 M histamine.
We have already shown HA-WT receptors to be
rapidly internalized from the cell surface after hista-
mine exposure [20]. We examined the role of palmi-
toylation in agonist-induced internalization. COS7
cells were transfected with plasmid DNAs containing
HA-WT (0.3 Wg/10 cm plate) or HA-A305 (1.5 Wg/10
cm plate) receptors. Transfection with these DNA
amounts resulted in similar levels of cell surface ex-
pression of HA-WT and HA-A305 receptors. At 60
min after 1035 M histamine administration, speci¢c
anti-HA antibody binding on COS7 cells expressing
the HA-WT receptors decreased by approx. 30%,
with a t1=2 of 15 min (Fig. 5). In contrast, the total
amount of receptor expression was unchanged after a
60 min incubation with 1035 M histamine (not
shown). These observations revealed HA-WT recep-
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tors to be internalized from the cell surface. A similar
decrease in anti-HA antibody binding was observed
in HA-A305 cells (Fig. 5). In addition, the total
amounts of HA-A305 receptors expressed were not
altered by incubation with 1035 M histamine for 60
min (not shown). Although the total amounts of
HA-A305 receptors expressed did not correlate with
the amounts of cell surface HA-A305 receptors as
demonstrated by immunocytochemistry (Fig. 2A),
cell surface HA-A305 receptors appeared to be inter-
nalized. Thus, palmitoylation of H2R is not essential
for agonist-induced internalization.
Finally, we examined the role of palmitoylation of
the receptor in agonist-induced downregulation. To
this end, we utilized CHO cell lines stably expressing
WT or the A305 receptors (termed CHO-WT and
CHO-A305, respectively), because the rate of receptor
synthesis was not constant in a transient expression
system using COS7 cells. These cell lines expressed
similar amounts of CHO-WT and CHO-A305 recep-
tors as determined by tiotidine binding (Fig. 6A).
Each cell line was incubated in the presence or ab-
sence of 1035 M histamine for 1, 6, 12 and 24 h.
Membrane fractions were prepared and receptor con-
tents, which represent total receptor amounts, were
determined by tiotidine binding. Fig. 6A shows that
incubation of CHO-WT cells with 1035 M histamine
for 24 h resulted in signi¢cant reductions in receptor
amounts, without altering tiotidine a⁄nity. An ap-
prox. 50% decrease in receptor contents was ob-
served, indicating downregulation. Interestingly, in-
cubation of CHO-A305 cells under the same
conditions resulted in a further reduction in receptor
amounts (Fig. 6A). A 70% decrease in receptor con-
tents was observed. Time courses of alterations in all
receptor amounts are shown in Fig. 6B. These ¢nd-
ings suggest the A305 receptor to be more prone to
downregulation than the WT receptor. Thus, palmi-
toylation of H2R might be important for its stability.
4. Discussion
In this study, using a baculovirus/Sf9 expression
system and site-directed mutagenesis, we were able
to demonstrate canine H2R to be palmitoylated at
Cys305. The primary ¢nding in this study is that the
subcellular distribution of the A305 receptor di¡ers
from that of the WT receptor. A larger portion of
A305 receptors was trapped intracellularly, while WT
receptors were located almost exclusively at the plas-
ma membrane. We observed in a previous study that
H2Rs with truncation of 70 C-terminal amino acids
(T289) were distributed in a manner similar to that of
the A305 receptor, while a T308 receptor with trunca-
tion of 51 C-terminal amino acids was distributed at
the plasma membranes [20]. The 70, but not the 51,
truncated amino acids of these receptors contained
Cys305, such that the T289 receptor was palmitoyla-
tion-defective. These ¢ndings indicate that the di¡er-
ences in subcellular distributions of the A305 receptor
are not due to the replacement of Cys305 by Ala, but
rather to the loss of palmitoylation secondary to this
replacement. Thus, palmitoylation of H2R is impor-
tant for its plasma membrane tra⁄cking. Cytoplas-
mic proteins require lipid modi¢cations, such as N-
myristoylation, palmitoylation and prenylation, for
membrane anchorage [25]. However, for membrane
proteins with transmembrane structures, lipid modi-
¢cation per se is not essential for plasma membrane
targeting, because a large number of membrane pro-
teins without palmitoylation are targeted to the plas-
Fig. 5. E¡ects of histamine treatment on amounts of cell sur-
face receptors or of total receptors. COS7 cells were transfected
with plasmid DNAs containing HA-WT (0.3 Wg/10 cm plate) or
HA-A305 (1.5 Wg/10 cm plate) receptors. Transfection with these
DNA amounts resulted in similar levels of cell surface expres-
sion of HA-WT and HA-A305 receptors. COS7 cells expressing
HA-WT or HA-A305 receptors on 24-well plates were incubated
with 1035 M histamine or vehicle for the indicated times, and
the cells were then ¢xed in 3% paraformaldehyde/PBS. Cell sur-
face anti-HA antibody binding was determined as described in
Section 2. b, HA-WT; F, HA-A305. Shown are the means
þ S.E. of three individual experiments, each performed in trip-
licate. When not shown, S.E. values were so small that they fell
within the symbols.
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ma membrane. Therefore, the e¡ect of the loss of
palmitoylation on the subcellular distribution of
H2R cannot be explained solely by the lack of pal-
mitoylation.
Because of the di¡erent distribution of the A305
receptor, it was di⁄cult to compare the function of
this receptor with that of the WT H2R. The cell
surface A305 receptor amount cannot be estimated
from the total receptor amount. In addition, there
are no hydrophilic radioligands for H2R which can
be used to detect cell surface receptors [23]. Thus, we
utilized the HA tag and anti-HA antibody to esti-
mate the cell surface receptor amount. We obtained
data using this system indicating that lack of palmi-
toylation did not a¡ect cAMP production via H2R.
Rather, the A305 receptor was more potent than WT
H2R in terms of stimulating adenylyl cyclase. For
the K2A-adrenoceptor, loss of palmitoylation did
not a¡ect functional coupling to G proteins [2]. Sim-
ilarly, arginine vasopressin V2 receptors, which were
mutated so as to be palmitoylation-defective, were
also functionally equivalent to WT in terms of ade-
nylyl cyclase activation [7]. The mutant L2-adreno-
ceptor which is devoid of a palmitoylation site
showed a reduced ability to mediate isoproterenol
stimulation of adenylyl cyclase [1]. However, this is
reportedly the result of increased accessibility of the
C-terminal portion to receptor kinases rather than
lack of palmitoylation [12]. Indeed, chemical depal-
mitoylation of the L2-adrenoceptor by hydroxyl-
amine did not a¡ect adenylyl cyclase activation via
the receptor [13]. Taken together, these ¢ndings sug-
gest that palmitoylation of GPCRs per se is not im-
portant for G protein coupling.
Fig. 6. E¡ects of prolonged histamine incubation on total receptor amounts. (A) Scatchard plot analysis of tiotidine binding to mem-
branes from treated and untreated cells. After incubation in the presence or absence of 1035 M histamine for 24 h, CHO-WT and
CHO-A305 cells were washed with PBS three times and membrane fractions were prepared. Membrane fractions (200 Wg) from these
cells were incubated with 1 nM [3H]tiotidine and varying concentrations of unlabeled tiotidine in 25 mM HEPES, 0.1% BSA, pH 7.4,
in a ¢nal volume of 200 Wl at 37‡C for 2 h. The binding reaction was terminated by ¢ltration over GF/C glass ¢ber ¢lters, followed
by 10 ml washes with ice-cold incubation bu¡er. Radioactivity on the ¢lters was determined by liquid scintillation counting. Speci¢c
binding was calculated by subtraction of the non-speci¢c binding determined in the presence of 1034 M ranitidine. Left panel, CHO-
WT cells, incubation in the presence (a) or absence (b) of histamine. Right panel, CHO-A305 cells, in the presence (E) or absence (F)
of histamine. Data shown are representative of three experiments performed in duplicate. (B) Time courses of alterations in Bmax of
tiotidine in membrane fractions from treated cells. CHO-WT and CHO-A305 cells were incubated in the presence or absence of 1035
M histamine for 1, 6, 12 and 24 h. Following washes with PBS, membranes were prepared and the Bmax of tiotidine was determined.
The Bmax of tiotidine in membranes from treated cells was expressed as a percentage of that from untreated cells. Note that the Bmax
of tiotidine in membranes from untreated cells remained constant throughout the incubation period. Shown are the means þ S.E. of
three individual experiments, each performed in duplicate. b, CHO-WT; F, CHO-A305
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In addition, we showed in this study that neither
desensitization nor agonist-induced internalization of
H2R is a¡ected by the loss of palmitoylation. Since
palmitoylation may function in membrane anchor-
age, creating a fourth intracellular loop, it is conceiv-
able that the conformation of the C-terminus of the
A305 receptor is di¡erent from that of WT. In a pre-
vious study, we showed the C-terminus of H2R to be
important for agonist-induced internalization, but
not for desensitization of the cAMP response [20].
Internalization of the A305 receptor also indicates
that the presence, rather than proper placement, of
the C-terminus, is important for the H2R internal-
ization process. Furthermore, it is noteworthy that
the A305 mutant, the subcellular distribution of which
is completely di¡erent from that of WT, was still
capable of internalization. This ¢nding indicates
that palmitoylation of H2R is involved in subcellular
distribution, but not in agonist-induced internaliza-
tion.
It is widely accepted that cAMP responses occur-
ring via H2R are rapidly desensitized after histamine
stimulation [17,20,26^29]. In this study, histamine-
dependent cAMP responses via the A305 receptor
were rapidly desensitized, to an extent comparable
to those via the WT receptor, indicating that palmi-
toylation is not essential for desensitization of the
cAMP response. This ¢nding is consistent with our
previous observation that truncation of the 51 C-ter-
minal amino acids (which corresponds to the distal
portion of the palmitoylation site) of H2R did not
a¡ect agonist-induced desensitization of the cAMP
response, suggesting that the residues important for
desensitization reside in other intracellular loops or
in the amino acid residues proximal to Cys305 [20]. In
the case of the L2-adrenoceptor, the C-terminus of
which is involved in desensitization, lack of palmi-
toylation led to increased phosphorylation of this
region and uncoupling from G proteins [12,13].
This occurs because loss of palmitoylation alters
the di¡erent conformation of the C-terminus, making
it more accessible to receptor kinases.
Finally, we have demonstrated in this study that
palmitoylation of H2R is not essential for agonist-
induced downregulation. Rather, the A305 receptor
was found to be more prone to downregulation. In
contrast, Eason et al. reported that loss of palmitoy-
lation in the K2A-adrenoceptor abolished agonist-in-
duced downregulation [11]. The roles of palmitoyla-
tion in downregulation might di¡er among receptors.
At any rate, it is noteworthy that A305 receptors, large
numbers of which were distributed intracellularly,
were downregulated more markedly than WT recep-
tors. This ¢nding clearly demonstrates that intracel-
lular A305 receptors were also a¡ected by 1035 M
histamine incubation. There are two possible explan-
ations for this ¢nding. First, it is possible that A305
receptors circulate between the plasma membrane
and cytoplasm, and when these receptors happen to
reach the plasma membrane they bind to histamine.
Alternatively, signaling via cell surface A305 receptors
might have downregulated intracellular A305 recep-
tors. In either case, we can conclude that intracellular
A305 receptors are regulated dynamically.
In conclusion, we have demonstrated in this study
that H2R is palmitoylated at Cys305 in the cytoplas-
mic C-terminal region. Furthermore, palmitoylation
is important for plasma membrane tra⁄cking but
not for H2R functions, such as ligand binding, ade-
nylyl cyclase stimulation, desensitization of cAMP
production, agonist-induced internalization and ago-
nist-induced downregulation.
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